Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabetic Mice with Nephropathy

Zeng Zhang,Xiaodong Fu,Fengzhu Zhou,Duanchun Zhang,Yanqiu Xu,Zhaohua Fan,Shimei Wen,Yanting Shao,Zheng Yao,Yanming He
DOI: https://doi.org/10.1155/2024/6942156
IF: 4.0608
2024-01-21
Journal of Diabetes Research
Abstract:Background. Better therapeutic drugs are required for treating hypertensive diabetic nephropathy. In our previous study, the Huaju Xiaoji (HJXJ) formula promoted the renal function of patients with diabetes and hypertensive nephropathy. In this study, we investigated the therapeutic effect and regulation mechanism of HJXJ in hypertensive diabetic mice with nephropathy. Methods. We constructed a mouse hypertensive diabetic nephropathy (HDN) model by treating mice with streptozotocin (STZ) and nomega-nitro-L-arginine methyl ester (LNAME). We also constructed a human glomerular mesangial cell (HGMC) model that was induced by high doses of sugar (30 mmol/mL) and TGFβ1 (5 ng/mL). Pathological changes were evaluated by hematoxylin and eosin (H&E) staining, periodic acid Schiff (PAS) staining, and Masson staining. The fibrosis-related molecules (TGFβ1, fibronectin, laminin, COL I, COL IV, α-SMA, and p-smad2/3) were detected by enzyme-linked immunosorbent assay (ELISA). The mRNA levels and protein expression of endoplasmic reticulum stress, fibrosis molecules, and their downstream molecules were assessed using qPCR and Western blotting assays. Results. Administering HJXJ promoted the renal function of HDN mice. HJXJ reduced the expression of ER stress makers (CHOP and GRP78) and lncMGC, miR379, miR494, miR495, miR377, CUGBP2, CPEB4, EDEM3, and ATF3 in HDN mice and model HGMCs. The positive control drugs (dapagliflozin and valsartan) also showed similar effects after treatment with HJXJ. Additionally, in model HGMCs, the overexpression of CHOP or lncMGC decreased the effects of HJXJ-M on the level of fibrosis molecules and downstream target molecules. Conclusion. In this study, we showed that the HJXJ formula may regulate ERS-lncMGC/miRNA to enhance renal function in hypertensive diabetic mice with nephropathy. This study may act as a reference for further investigating whether combining HJXJ with other drugs can enhance its therapeutic effect. The findings of this study might provide new insights into the clinical treatment of hypertensive diabetic nephropathy with HJXJ.
endocrinology & metabolism,medicine, research & experimental
What problem does this paper attempt to address?
The paper aims to investigate the therapeutic effects and mechanisms of the Huajuxiaoji (HJXJ) formula on nephropathy in mice with diabetic hypertension (HDN). Specifically, the study found that the HJXJ formula can improve kidney function in these mice by regulating endoplasmic reticulum stress (ERS)-related long non-coding RNA (lncMGC) and microRNA (miRNA). The main findings include: - The HJXJ formula significantly reduced the levels of urinary protein, serum creatinine, and blood urea nitrogen in mice with diabetic hypertension. - The HJXJ formula decreased the expression of ERS markers (such as CHOP and GRP78) as well as lncMGC and related miRNAs (such as miR379, miR494, miR495, and miR377). - In a high glucose and TGF-β1 induced human glomerular mesangial cell (HGMC) model, HJXJ also showed similar effects. - Additionally, the HJXJ formula reduced the levels of fibrosis-related molecules (such as TGF-β1, fibronectin, laminin, collagen I, and IV) and affected the expression of downstream molecules (such as α-SMA and p-smad2/3). In conclusion, this study reveals the potential mechanism by which the HJXJ formula enhances kidney function in mice with diabetic hypertension by regulating the ERS-lncMGC/miRNA pathway, providing new insights for clinical treatment.